Renal impairment
AC-055-112
Objectives: Investigation of the PK in patients with impaired renal function. Safety and tolerability.
Enrolled and Evaluable (PK and safety): 8 patients with severe renal impairment, 8 healthy subjects.
Demographics: 8 subjects with severe renal impairment (creatinine clearance range: 16.1–29.0 mL/min), 8 healthy subjects (creatinine clearance range: 89.9–107.4 mL/min); 8 male, 8 female; Caucasian; Age: 36–60 years; Weight: 63.0–90.4 kg; BMI: 22.2–31.1 kg/m2.
Treatments: Single oral macitentan 10 mg tablet.
Design: Open-label, parallel group
Spermatogenesis
AC-055-113